查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1844171

手动人工呼吸器市场按最终用户、产品类型、营运模式和销售管道划分—2025-2032 年全球预测

Manual Resuscitators Market by End User, Product Type, Mode Of Operation, Sales Channel - Global Forecast 2025-2032
出版日期: | 出版商: 360iResearch | 英文 190 Pages | 商品交期: 最快1-2个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

预计到 2032 年手动人工呼吸器市场规模将成长至 9.9363 亿美元，复合年增长率为 7.54%。

主要市场统计数据
基准年2024年 5.5512亿美元
预计2025年 5.9754亿美元
预测年份：2032年 9.9363亿美元
复合年增长率（%） 7.54%

确定手动人工呼吸器在现代急诊和住院护理途径中的作用，并确定采购和临床可用性的优先事项

手动人工呼吸器市场正处于临床紧急程度、製造标准和不断发展的医疗保健系统期望的交汇点，这给医疗保健提供者、经销商和製造商的决策者带来了挑战，使他们必须清晰地了解情况。手动人工呼吸器仍然是医疗保健环境中用于即时呼吸道管理和呼吸支援的核心关键干预设备，而近期临床指南、灭菌方法和采购管道的变化也增加了对严谨资讯的需求。本介绍将该设备置于现代护理路径和供应链的现实中，同时强调性能、易用性和法规合规性是其被广泛采用的关键决定因素。

在各种护理环境中，手动人工呼吸器的评估不仅基于其即时救生能力，还基于其人体工学、材料成分以及与辅助设备的兼容性。采购团队目前正在权衡耐用性、再处理要求、最终用户偏好以及在各种使用条件下保障患者安全的需求。同时，设备製造商必须应对复杂的监管环境，并结合临床医生的回馈，改善设计、材料和标籤，从而提高有效性和易用性。

本节为深入探讨影响供需的系统性变化奠定了基础。本章指出，人工呼吸器是高阶通气支持的重要临床补充，也是灾难准备的关键组成部分。透过阐明临床角色、营运限制和采购考虑因素，本引言将帮助读者理解后续对政策影响、细分市场细微差别、区域动态以及产业相关人员策略反应的分析。

材料创新、法规收紧以及供应链的演变如何重新定义紧急通风领域的产品设计选择和采购优先级

手动人工呼吸器的格局正在被多种变革力量再形成，这些力量正在改变设备的设计、采购和使用方式。材料科学和一次性设备工程的进步正在改变关于一次性使用与重复使用选择的讨论，而新的灭菌通讯协定和环境问题则促使人们更加关注其生命週期的影响。同时，监管审查的加强和临床指南的更新也要求製造商提供可靠的性能证据和清晰的使用说明，同时也要满足可追溯性和上市后监管的要求。

供应链动态也是变革的关键因素，买家和製造商优先考虑多样化的筹资策略和库存弹性。分销管道也在不断发展，除了传统的分销商网络外，数位采购平台和直接供应商关係也越来越受到青睐。临床医生的工作流程和培训计划正在调整，以融入特定于设备的功能，例如安全装袋技术以及与辅助气道设备的集成，这进一步强调了人因工程和清晰标籤检视的重要性。

整合以临床医生为中心的设计、检验的灭菌途径和透明合规性的製造商将在医疗机构中获得更高的认可度，而规范设备选择标准的医疗系统将能够更好地协调临床结果与运营效率。最终结果是，市场将奖励设计创新、监管严谨性和供应链适应性。

评估近期关税变化和贸易政策调整将如何迫使救生气道设备的供应链重组和筹资策略

影响跨境贸易和进口关税的政策变化，为製造商、经销商和医疗保健提供者带来了新的营运考量。关税调整和相关的行政措施可能会增加到岸成本，使供应商合约复杂化，并鼓励企业采取近岸外包或本地筹资策略。企业正在透过审查其供应商组合、合约条款和库存政策来应对，以保持临床的连续性，同时应对日益复杂的交易和潜在的利润压力。

关税不仅影响成本，还会影响製造地决策和资本配置。一些製造商正在加大力度，透过本地化部分价值链、优先考虑双重采购安排以及重新设计包装和产品配置，最大限度地降低关税的影响。采购团队也同样采用更细緻的整体拥有成本分析，将关税、物流和合规成本纳入其中，以便在价格、前置作业时间和供应商韧性之间做出更明智的权衡。

临床医生和医院管理人员受到采购週期和预算限制的影响，这些因素可能会改变采购计划和设备标准化倡议。为了缓解此类干扰，相关人员正在扩大供应商资格标准，在区域卫生网路之间建立合作协议，并寻求贸易和关税顾问的明确指导。近期关税行动的累积效应凸显了在供应规划、合约谈判和资本部署决策中了解贸易政策的重要性，同时又不损害患者照护的标准。

深度细分主导的洞察揭示了最终用户环境、产品组合、再处理要求和分销管道如何影响设备采用

要了解市场行为，需要仔细注意最终用户、产品形态、营运模式和销售管道如何影响需求和采用模式。最终使用者环境包括门诊中心、紧急医疗服务、家庭医疗保健和医院，而医院又进一步细分为私立医院、公立医院和教学医院。每种环境都有其独特的临床工作流程、库存管理实务和采购要求，这些都会影响产品偏好和规格要求。例如，紧急医疗服务优先考虑紧凑、易于操作且在现场条件下性能可靠的设备，而教学医院则重视坚固耐用且能够承受反覆训练、模拟使用以及临床护理的设备。

产品类型分为成人、婴儿、新生儿和儿科，每个类别都需要尺寸、压力释放功能和材料来满足患者群体的生理需求。可重复使用器械的特点还包括高压釜和不可高压釜的结构，以及再处理工作流程和生命週期的差异。一次性使用器械则分为无菌和非无菌两种，这会影响在需要严格无菌处理的环境中以及优先考虑成本控制和简化供应链的环境中临床应用。

销售管道涵盖直销、医院分销商、线上通路和零售药局。线上通路包括企业网站和电商门户，而零售药局则包括连锁药局和独立药局。这些管道对订单处理速度、捆绑服务以及售后服务支援有着不同的期望。直销能够实现更紧密的临床参与和客製化配置，而分销商则提供广泛的产品组合和物流专业知识。电商和零售药局通路扩大了居家医疗客户和小型买家的管道，他们重视便利性以及透明的退货和保固政策。整合这些细分维度，可以为整个价值链上的相关人员提供对使用者需求、产品开发重点和分销策略的细緻入微的视角。

区域医疗保健体系结构、法规环境和分销模式如何推动差异化采用和商业化方法

美洲、欧洲、中东和非洲以及亚太地区的区域动态对临床实务、监管预期和筹资策略有着不同的影响。在美洲，采购週期通常与大型综合医疗保健系统和急救医疗服务 (EMS) 网路交叉，因此非常重视与现有设备的互通性以及与供应商签订合约的便利性。该地区对紧急准备和灾难应变能力的重视，通常会促使人们对经济高效的可重复使用系统和一次性设备产生兴趣，以满足激增的需求。

在欧洲、中东和非洲，监管协调、多元化的支付方结构以及多样化的医院所有权模式影响着产品的选择和采购时间表。教学医院和专科医疗中心通常会采用符合严格培训和性能要求的设备，而公立医院则可能优先考虑符合当地采购法规且经济高效的解决方案。在亚太地区，医疗基础设施的快速扩张、公立和私立医疗机构的混合以及对本地製造和分销管道的重视，共同塑造医疗需求。在亚太地区营运的製造商会留意不同国家/地区灭菌实践和临床通讯协定的差异，这些差异会影响产品设计和标籤策略。

这些区域差异导致了不同的供应商合约模式和商业策略。例如，医院系统复杂的地区可能优先考虑直销和临床教育项目，而重视地理覆盖范围更广和零售商通路的地区则可能利用分销商合作伙伴关係和电子商务策略。认识到这些细微差别可以帮助相关人员根据当地需求和采购行为调整产品系列、监管途径和供应链。

评估影响采购和临床应用的竞争优势和策略能力，从全方位服务製造商到利基创新者

市场领导和新兴企业在产品开发、品管和商业性执行方面为这一领域带来了不同的优势。成熟的製造商通常受益于垂直整合的品质系统、成熟的灭菌验证以及长期的临床合作关係，这有助于将其产品纳入医院处方集和紧急医疗服务 (EMS) 规范。这些能力透过对人因工程、临床医生培训计画和强大的上市后监测流程的投资得到增强，从而减少了产品采用过程中的摩擦，并增强了采购委员会的信心。

规模较小的创新者和利基製造商通常专注于有针对性的改进，例如轻量化材料、提升阀门性能或解决临床医生特定痛点的模组化组件。这些公司可以利用与经销商和临床培训中心的策略伙伴关係关係来加速采用并收集实际绩效回馈。同时，契约製造製造商和医疗设备组装也发挥着至关重要的作用，它们使大型公司能够快速扩大生产规模，满足多样化市场的需求，同时保持品管和合规性。

在这种竞争格局中，成功的企业能够兼顾监管应对力、临床医生参与度和供应链韧性。他们优先考虑清晰的标籤和使用说明，在适用的情况下投资灭菌验证，并创建商业模式，以满足医院、急诊、门诊中心和家庭医疗保健提供者的不同购买行为。这种多管齐下的方法既有助于市场准入，又能长期维持用户满意度。

医疗设备製造商和供应商可采取的策略性倡议，以提高临床相关性、增强供应弹性并扩大医疗环境中的可及性

行业领导者应采用整合方法，将以临床医生为中心的设计、清晰的监管和敏捷的供应链相结合，以保持市场相关性和营运韧性。优先投资人为因素测试和临床医生培训材料，以确保设备即使在高压力情况下也能直观使用，并在预期用例中始终保持性能一致。在产品开发过程中，应为可重复使用产品提供严格的无菌验证，并为一次性产品提供清晰的无菌标籤，以减少采用障碍并增强采购信心。

多元化供应商并提高近期库存的透明度，可以降低贸易政策变化和物流瓶颈带来的风险。与经销商和大型医疗系统协商灵活的合约条款，以适应紧急计划和紧急采购需求。同时，利用电商和零售药局的关係，触达家庭医疗保健领域以及重视可及性和快速履约的小型买家。

最后，协调商业和监管团队，简化跨司法管辖区的市场准入，并投资于上市后资料收集，以支援持续改善和合规。透过结合实用的临床检验、有弹性的筹资策略和有针对性的上市模式，领导者可以确保持久的供应商关係，并建立能够适应不断变化的临床和政策环境的产品组合。

一种透明、多方法的研究途径，结合临床医生访谈、监管调查和供应链分析，以获取与您的业务相关的信息

初步研究采用多方法论，整合了相关人员访谈、法规和标准研究以及对临床实践指南和医疗设备附加檔的系统性综述。初步访谈涵盖了临床医生、采购负责人、经销商高阶主管和生产品管经理，以了解实务实务、使用者偏好和采购限制。这些定性见解与官方监管文件、产品使用说明和灭菌验证报告的审查相结合，以确认临床预期与技术规范之间的一致性。

次要分析包括分销模式和供应链配置的比较研究，以及已发表的紧急呼吸道管理相关临床指南和共识声明的回顾。在可行的情况下，我们查阅了该设备的技术文献和人为因素研究，以评估设计权衡及其对再处理的影响。我们参考了贸易政策和海关建议，讨论了关税和跨境采购方面的考虑因素，并聘请了物流专家来解读其对前置作业时间和库存计划的影响。

这种混合调查方法强调透明度、可重复性和实用性。它强调定性的深度和跨职能验证，而非定量的市场估计和预测，旨在为寻求产品策略与商业现实和监管要求相符的临床采购团队、製造商和分销合作伙伴提供可操作的资讯。

摘要设计、无菌处理、法规遵循和供应弹性之间的相互作用，这对于维持紧急气道设备的临床使用至关重要

手动人工呼吸器仍然是紧急呼吸护理的基本组成部分，其发展受到技术进步、采购惯例变化以及影响供应链和设备选择的政策发展的影响。相关人员必须平衡临床表现、再处理要求和配送实际情况，以适应门诊中心、急诊医疗服务 (EMS)、居家医疗和多样化的医院模式。在速度和可靠性至关重要的环境中，对人为因素的关注、无菌验证和清晰的标籤仍然是区分不同设备的关键。

贸易政策和关税的变化加剧了商业性复杂性，迫使监管、采购和供应链团队更加紧密地合作。积极拥抱采购多元化、合约灵活性和区域监管途径的製造商和买家将更有能力保持供应的连续性并维护临床标准。同时，从与医疗保健提供者的直接关係到电子商务和零售药局的管道，不断发展的销售管道创造了扩大覆盖范围的机会，同时满足了医疗保健和消费者市场的独特需求。

摘要，务实且以临床医生为导向的方法，将卓越的设计、合规性和供应链弹性融为一体，能够为企业提供协助。透过专注于这些基本要求，製造商、经销商和医疗保健提供者可以提高设备的可用性，并确保手动人工呼吸器在每个护理环节继续发挥至关重要的救生作用。

目录

第一章：前言

第二章调查方法

第三章执行摘要

第四章 市场概况

第五章 市场洞察

  • 将智慧感测器和回馈机制整合到手动復苏设备中可提高患者安全性
  • 感染控制问题推动紧急医疗服务对一次性手动人工呼吸器的需求
  • 开发用于现场应用的具有即时通气监测功能的可携式电池供电手动人工呼吸器
  • 手动人工呼吸器采用符合人体工学的轻质材料製成，可提高临床医生在长期使用过程中的舒适度。
  • 整合数位监控和资料登录系统的高级手动人工呼吸器面临的监管核准挑战
  • 随着主要製造商收购智慧人工呼吸器Start-Ups并扩大产品系列，竞争格局正在改变。
  • 全球供应链中断对医用级手动人工呼吸器零件供应和价格波动的影响

第六章：2025年美国关税的累积影响

第七章：人工智慧的累积影响，2025年

8. 手动人工呼吸器市场（按最终用户）

  • 门诊中心
  • 紧急医疗服务
  • 家庭医疗保健
  • 医院
    • 私立医院
    • 公立医院
    • 教学医院

9. 手动人工呼吸器市场（依产品类型）

  • 成人
  • 婴儿
  • 新生
  • 孩子们

第 10 章手动人工呼吸器市场（按操作模式）

  • 可重复使用的
    • 高压釜
    • 请勿高压釜
  • 一次性的
    • 非无菌
    • 已灭菌

第 11 章：手动人工呼吸器市场（依销售管道）

  • 直销
  • 医院经销商
  • 线上管道
    • 公司网站
    • 电子商务入口网站
  • 零售药局
    • 连锁药局
    • 独立药房

12. 手动人工呼吸器市场（按地区）

  • 美洲
    • 北美洲
    • 拉丁美洲
  • 欧洲、中东和非洲
    • 欧洲
    • 中东
    • 非洲
  • 亚太地区

第 13 章。手动人工呼吸器市场（按类别）

  • ASEAN
  • GCC
  • EU
  • BRICS
  • G7
  • NATO

第 14 章。按国家/地区分類的手动人工呼吸器市场

  • 美国
  • 加拿大
  • 墨西哥
  • 巴西
  • 英国
  • 德国
  • 法国
  • 俄罗斯
  • 义大利
  • 西班牙
  • 中国
  • 印度
  • 日本
  • 澳洲
  • 韩国

第十五章竞争格局

  • 2024年市占率分析
  • 2024年FPNV定位矩阵
  • 竞争分析
    • Ambu A/S
    • Cardinal Health, Inc.
    • Teleflex Incorporated
    • Vyaire Medical, Inc.
    • Medline Industries, LP
    • Draegerwerk AG & Co. KGaA
    • Nihon Kohden Corporation
    • GE Healthcare Technologies, Inc.
    • Mindray Medical International Limited
    • Becton, Dickinson and Company
Product Code: MRR-ED54C46E8737

The Manual Resuscitators Market is projected to grow by USD 993.63 million at a CAGR of 7.54% by 2032.

KEY MARKET STATISTICS
Base Year [2024] USD 555.12 million
Estimated Year [2025] USD 597.54 million
Forecast Year [2032] USD 993.63 million
CAGR (%) 7.54%

Clarifying the role of manual resuscitators within modern emergency and inpatient care pathways while highlighting procurement and clinical usability priorities

The manual resuscitator market intersects clinical urgency, manufacturing standards, and evolving health system expectations, demanding clarity for decision-makers across providers, distributors, and manufacturers. Manual resuscitators remain a core emergency intervention device used across care settings for immediate airway management and ventilation support, and recent shifts in clinical guidelines, sterilization practice, and procurement channels have heightened the need for rigorous intelligence. This introduction situates the device within contemporary care pathways and supply chain realities while emphasizing performance, usability, and regulatory alignment as critical determinants of adoption.

Across care environments, manual resuscitators are evaluated not only for their immediate lifesaving capability but also for their ergonomics, material composition, and compatibility with ancillary equipment. Procurement teams now balance durability, reprocessing requirements, and end-user preferences with the imperative to maintain patient safety under varying operating conditions. In parallel, device manufacturers must navigate a complex regulatory landscape and incorporate clinician feedback to refine design, materials, and labeling that improve both efficacy and usability.

This section sets the stage for a deeper exploration of systemic changes shaping demand and supply. It frames the device as an essential clinical complement to advanced ventilatory supports and a critical component of disaster preparedness. By clarifying clinical roles, operational constraints, and procurement considerations, the introduction prepares readers to interpret subsequent analyses on policy impacts, segmentation nuances, regional dynamics, and strategic responses by industry stakeholders.

How material innovations, regulatory tightening, and supply chain evolution are redefining product design choices and procurement priorities in emergency ventilation

The landscape for manual resuscitators has been reshaped by several transformative forces that alter how devices are designed, procured, and used. Advances in materials science and disposable device engineering have shifted conversations about single-use versus reusable options, and emerging sterilization protocols and environmental concerns have amplified attention on lifecycle impacts. Simultaneously, heightened regulatory scrutiny and updated clinical guidelines are prompting manufacturers to demonstrate robust performance evidence and clear instructions for use, while also addressing traceability and post-market surveillance requirements.

Supply chain dynamics constitute another major vector of change, with buyers and manufacturers emphasizing diversified sourcing strategies and inventory resilience. Distribution channels are evolving too, as digital procurement platforms and direct-to-provider relationships gain traction alongside traditional distributor networks. Clinician workflows and training programs have adapted to incorporate device-specific competencies, including safe bagging techniques and integration with adjunct airway equipment, which has reinforced the importance of human factors engineering and clear labeling.

Taken together, these shifts create both opportunity and obligation: manufacturers that integrate clinician-centric design, validated sterilization pathways, and transparent regulatory compliance will find stronger acceptance across care settings, while health systems that codify device selection criteria can better align clinical outcomes with operational efficiency. The net effect is a market that rewards innovation in design, regulatory rigor, and supply chain adaptability.

Assessing how recent tariff changes and trade policy adjustments compel supply chain realignment and procurement strategies for life-saving airway devices

Policy changes affecting cross-border trade and import duties have introduced new operational considerations for manufacturers, distributors, and healthcare providers. Tariff adjustments and associated administrative measures can increase landed costs, complicate supplier contracts, and incentivize nearshoring or regional sourcing strategies. Organizations respond by reassessing supplier portfolios, contract terms, and inventory policies to preserve clinical continuity while managing increased transactional complexity and potential margin pressure.

Beyond cost implications, tariffs influence manufacturing footprint decisions and capital allocation. Some manufacturers have intensified efforts to localize portions of their value chains, prioritize dual-sourcing arrangements, or redesign packaging and product configurations to minimize tariff exposure. Procurement teams are likewise adopting more granular total-cost-of-ownership analyses that incorporate duty, logistics, and compliance overhead, enabling more informed trade-offs between price, lead time, and supplier resilience.

Clinicians and hospital administrators are affected through procurement cycles and budgetary constraints that can alter purchasing timelines and device standardization initiatives. To mitigate these disruptions, stakeholders are expanding supplier qualification criteria, engaging in collaborative contracting across regional health networks, and seeking clarity from trade and customs advisors. The cumulative effect of recent tariff actions underscores the importance of integrating trade policy awareness into supply planning, contract negotiation, and capital deployment decisions without compromising patient care standards.

Deep segmentation-driven insights that reveal how end-user environments, product configurations, reprocessing requirements, and distribution channels shape device adoption

Understanding market behavior requires close attention to how different end users, product forms, modes of operation, and sales channels shape demand and adoption patterns. End-user settings include ambulatory centers, emergency medical services, home healthcare, and hospitals, with hospitals further differentiated into private hospitals, public hospitals, and teaching hospitals; each setting imposes distinct clinical workflows, stocking practices, and purchasing authorities that influence product preferences and specification requirements. For example, emergency medical services prioritize compact, easy-to-operate devices that perform reliably under field conditions, whereas teaching hospitals emphasize devices that are robust for repeated training and simulation use as well as clinical care.

Product-type segmentation spans adult, infant, neonatal, and pediatric devices, with each category demanding tailored sizing, pressure relief features, and materials suited to the physiological needs of the patient population. Mode-of-operation divides offerings into reusable and single-use configurations; reusable devices are further characterized by autoclave-compatible and non-autoclavable constructions that carry differential reprocessing workflows and lifecycle considerations. Single-use options are examined through the lens of sterile and non-sterile variants, which affect clinical adoption in settings that require strict aseptic handling and those that prioritize cost containment and supply chain simplicity.

Sales channels range from direct sales and hospital distributors to online channels and retail pharmacies, with online channels including company websites and e-commerce portals, and retail pharmacies encompassing chain pharmacies and independent pharmacies. These channels present different expectations around order fulfillment speed, bundled service offerings, and after-sales support. Direct sales enable closer clinical engagement and customized configurations, whereas distributors offer breadth of portfolio and logistics expertise. E-commerce and retail pharmacy routes broaden access for home healthcare customers and smaller buyers, emphasizing convenience and transparent returns and warranty policies. Integrating these segmentation dimensions provides a nuanced view of user needs, product development priorities, and distribution strategies for stakeholders across the value chain.

How regional healthcare system structures, regulatory environments, and distribution models drive differentiated adoption and commercialization approaches

Regional dynamics influence clinical practice, regulatory expectations, and sourcing strategies in distinct ways across the Americas, Europe, Middle East & Africa, and Asia-Pacific regions. In the Americas, procurement cycles often intersect with large integrated health systems and EMS networks, which place a premium on device interoperability with existing equipment and straightforward supplier contracting. This region's emphasis on emergency preparedness and disaster response capabilities often drives interest in both reusable systems for cost efficiency and single-use devices to meet surge demands.

Across Europe, Middle East & Africa, regulatory harmonization, diverse payor structures, and varied hospital ownership models affect product selection and procurement timelines. Teaching hospitals and specialized care centers frequently lead in adopting devices that meet exacting training and performance requirements, while public hospitals may prioritize cost-effective solutions that comply with regional procurement rules. In Asia-Pacific, rapid expansion of healthcare infrastructure, a mix of public and private providers, and an emphasis on localized manufacturing and distribution channels shape demand. Manufacturers operating in Asia-Pacific are attentive to variations in sterilization practices and clinical protocols across countries, which influences product design and labeling strategies.

These regional distinctions drive different supplier engagement models and commercial tactics. For instance, companies may prioritize direct sales and clinical education programs in regions with complex hospital systems, while leveraging distributor partnerships and e-commerce strategies where broader geographic coverage and retail access are critical. Recognizing these nuances helps stakeholders align product portfolios, regulatory pathways, and supply chains to regional needs and procurement behaviors.

Evaluating competitive strengths and strategic capabilities from integrated manufacturers to niche innovators that influence procurement and clinical adoption

Market leaders and emerging players bring differing strengths to product development, quality management, and commercial execution in this segment. Established manufacturers often benefit from vertically integrated quality systems, proven sterilization validations, and longstanding clinical relationships that facilitate hospital formulary inclusion and EMS specifications. These capabilities are reinforced by investments in human factors engineering, clinician training programs, and robust post-market surveillance processes that reduce adoption friction and build trust among procurement committees.

Smaller innovators and niche manufacturers frequently focus on targeted improvements such as lightweight materials, enhanced valve performance, and modular components that address specific clinician pain points. These companies may use strategic partnerships with distributors or clinical training centers to accelerate adoption and gather real-world performance feedback. In parallel, contract manufacturers and medical device assemblers play a pivotal role by enabling larger players to scale production rapidly while maintaining quality controls and regulatory compliance for diverse markets.

Across the competitive landscape, successful companies combine regulatory proficiency, clinician engagement, and supply chain resilience. They also prioritize clear labeling and instructions for use, invest in sterilization validation where applicable, and structure commercial models that address the different purchasing behaviors of hospitals, EMS, ambulatory centers, and home healthcare providers. This multifaceted approach supports both market access and long-term user satisfaction.

Actionable strategic moves for device manufacturers and suppliers to sharpen clinical relevance, bolster supply resilience, and expand access across care settings

Industry leaders should adopt an integrated approach that combines clinician-centered design, regulatory clarity, and supply chain agility to maintain market relevance and operational resilience. Prioritize investments in human factors testing and clinician training materials to ensure devices are intuitive in high-stress scenarios and demonstrate consistent performance across intended use cases. Complement product development with robust sterilization validation for reusable offerings and clear sterile labeling for single-use variants to reduce barriers to adoption and support procurement confidence.

Strengthening supplier diversification and near-term inventory visibility will mitigate exposure to trade policy shifts and logistical bottlenecks. Negotiate flexible contract terms with distributors and large health systems that accommodate contingency planning and surge procurement needs. In parallel, expand commercial channels thoughtfully: use direct engagement for institutional customers that require clinical training and customization, while leveraging e-commerce and retail pharmacy relationships to reach home healthcare segments and smaller buyers who prioritize ease of access and rapid fulfillment.

Finally, align commercial and regulatory teams to streamline market entry across jurisdictions, and invest in post-market data collection to support continuous improvement and compliance. By combining practical clinical validation, resilient sourcing strategies, and targeted go-to-market models, leaders can secure durable relationships with providers and position their portfolios to respond to evolving clinical and policy environments.

A transparent multi-method research approach combining clinician interviews, regulatory review, and supply chain analysis to derive operationally relevant intelligence

The research synthesis is grounded in a multi-method approach that integrates primary stakeholder interviews, regulatory and standards reviews, and a systematic evaluation of clinical practice guidelines and device labeling. Primary interviews encompassed clinicians, procurement officers, distributor executives, and manufacturing quality leads to capture operational realities, user preferences, and procurement constraints. These qualitative insights were triangulated with an examination of public regulatory documents, product instructions for use, and sterilization validation reports to ensure alignment between clinical expectations and technical specifications.

Secondary analysis included a comparative study of distribution models and supply chain configurations, along with a review of published clinical guidelines and consensus statements related to emergency airway management. Where available, device technical literature and human factors studies were examined to assess design trade-offs and reprocessing implications. Trade policy and customs advisories were consulted to frame discussions of tariff and cross-border sourcing considerations, and logistics experts were engaged to interpret implications for lead times and inventory planning.

This blended methodology emphasizes transparency, reproducibility, and practical relevance. It focuses on qualitative depth and cross-functional corroboration rather than projecting numerical market estimates, and it is designed to yield actionable intelligence for clinical procurement teams, manufacturers, and distribution partners seeking to align product strategy with operational realities and regulatory obligations.

Summarizing the essential interplay of design, sterilization practice, regulatory alignment, and supply resilience that sustains clinical use of emergency airway devices

Manual resuscitators remain a foundational element of emergency respiratory care, shaped by technological refinements, shifting procurement practices, and policy developments that influence supply chains and device selection. Stakeholders must balance clinical performance, reprocessing requirements, and distribution pragmatics to maintain readiness across ambulatory centers, EMS, home healthcare, and diverse hospital types. Attention to human factors, sterilization validation, and clear labeling will continue to differentiate devices in environments where speed and reliability are paramount.

Trade policy and tariff changes add a layer of commercial complexity that requires closer coordination between regulatory, procurement, and supply chain teams. Manufacturers and buyers who proactively address sourcing diversity, contractual flexibility, and regional regulatory pathways will be better positioned to sustain supply continuity and maintain clinical standards. At the same time, evolving sales channels-from direct institutional relationships to e-commerce and retail pharmacy access-create opportunities to broaden reach while meeting the distinct needs of institutional and consumer markets.

In summary, a pragmatic, clinician-informed approach that integrates design excellence, regulatory diligence, and supply chain resilience will serve organizations well. By focusing on these imperatives, manufacturers, distributors, and healthcare providers can enhance device availability and ensure that manual resuscitators continue to fulfill their essential lifesaving role across care settings.

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Integration of smart sensors and feedback mechanisms in manual resuscitator devices for enhanced patient safety
  • 5.2. Rising demand for disposable single-use manual resuscitators in emergency medical services due to infection control concerns
  • 5.3. Development of portable battery-operated manual resuscitators with real-time ventilation monitoring for field applications
  • 5.4. Adoption of ergonomic lightweight materials in manual resuscitator manufacturing for improved clinician comfort during prolonged use
  • 5.5. Regulatory approval challenges for advanced manual resuscitators with integrated digital monitoring and data logging systems
  • 5.6. Competitive landscape shift driven by major manufacturers acquiring smart resuscitator startups to expand product portfolios
  • 5.7. Impact of global supply chain disruptions on availability and pricing volatility of medical-grade manual resuscitator components

6. Cumulative Impact of United States Tariffs 2025

7. Cumulative Impact of Artificial Intelligence 2025

8. Manual Resuscitators Market, by End User

  • 8.1. Ambulatory Centers
  • 8.2. Emergency Medical Services
  • 8.3. Home Healthcare
  • 8.4. Hospitals
    • 8.4.1. Private Hospitals
    • 8.4.2. Public Hospitals
    • 8.4.3. Teaching Hospitals

9. Manual Resuscitators Market, by Product Type

  • 9.1. Adult
  • 9.2. Infant
  • 9.3. Neonatal
  • 9.4. Pediatric

10. Manual Resuscitators Market, by Mode Of Operation

  • 10.1. Reusable
    • 10.1.1. Autoclavable
    • 10.1.2. Non-Autoclavable
  • 10.2. Single-Use
    • 10.2.1. Non-Sterile
    • 10.2.2. Sterile

11. Manual Resuscitators Market, by Sales Channel

  • 11.1. Direct Sales
  • 11.2. Hospital Distributors
  • 11.3. Online Channels
    • 11.3.1. Company Websites
    • 11.3.2. E-Commerce Portals
  • 11.4. Retail Pharmacies
    • 11.4.1. Chain Pharmacies
    • 11.4.2. Independent Pharmacies

12. Manual Resuscitators Market, by Region

  • 12.1. Americas
    • 12.1.1. North America
    • 12.1.2. Latin America
  • 12.2. Europe, Middle East & Africa
    • 12.2.1. Europe
    • 12.2.2. Middle East
    • 12.2.3. Africa
  • 12.3. Asia-Pacific

13. Manual Resuscitators Market, by Group

  • 13.1. ASEAN
  • 13.2. GCC
  • 13.3. European Union
  • 13.4. BRICS
  • 13.5. G7
  • 13.6. NATO

14. Manual Resuscitators Market, by Country

  • 14.1. United States
  • 14.2. Canada
  • 14.3. Mexico
  • 14.4. Brazil
  • 14.5. United Kingdom
  • 14.6. Germany
  • 14.7. France
  • 14.8. Russia
  • 14.9. Italy
  • 14.10. Spain
  • 14.11. China
  • 14.12. India
  • 14.13. Japan
  • 14.14. Australia
  • 14.15. South Korea

15. Competitive Landscape

  • 15.1. Market Share Analysis, 2024
  • 15.2. FPNV Positioning Matrix, 2024
  • 15.3. Competitive Analysis
    • 15.3.1. Ambu A/S
    • 15.3.2. Cardinal Health, Inc.
    • 15.3.3. Teleflex Incorporated
    • 15.3.4. Vyaire Medical, Inc.
    • 15.3.5. Medline Industries, L.P.
    • 15.3.6. Draegerwerk AG & Co. KGaA
    • 15.3.7. Nihon Kohden Corporation
    • 15.3.8. GE Healthcare Technologies, Inc.
    • 15.3.9. Mindray Medical International Limited
    • 15.3.10. Becton, Dickinson and Company

LIST OF FIGURES

  • FIGURE 1. GLOBAL MANUAL RESUSCITATORS MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 2. GLOBAL MANUAL RESUSCITATORS MARKET SIZE, BY END USER, 2024 VS 2032 (%)
  • FIGURE 3. GLOBAL MANUAL RESUSCITATORS MARKET SIZE, BY END USER, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 4. GLOBAL MANUAL RESUSCITATORS MARKET SIZE, BY PRODUCT TYPE, 2024 VS 2032 (%)
  • FIGURE 5. GLOBAL MANUAL RESUSCITATORS MARKET SIZE, BY PRODUCT TYPE, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 6. GLOBAL MANUAL RESUSCITATORS MARKET SIZE, BY MODE OF OPERATION, 2024 VS 2032 (%)
  • FIGURE 7. GLOBAL MANUAL RESUSCITATORS MARKET SIZE, BY MODE OF OPERATION, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 8. GLOBAL MANUAL RESUSCITATORS MARKET SIZE, BY SALES CHANNEL, 2024 VS 2032 (%)
  • FIGURE 9. GLOBAL MANUAL RESUSCITATORS MARKET SIZE, BY SALES CHANNEL, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 10. GLOBAL MANUAL RESUSCITATORS MARKET SIZE, BY REGION, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 11. AMERICAS MANUAL RESUSCITATORS MARKET SIZE, BY SUBREGION, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 12. NORTH AMERICA MANUAL RESUSCITATORS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 13. LATIN AMERICA MANUAL RESUSCITATORS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 14. EUROPE, MIDDLE EAST & AFRICA MANUAL RESUSCITATORS MARKET SIZE, BY SUBREGION, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 15. EUROPE MANUAL RESUSCITATORS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 16. MIDDLE EAST MANUAL RESUSCITATORS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 17. AFRICA MANUAL RESUSCITATORS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 18. ASIA-PACIFIC MANUAL RESUSCITATORS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 19. GLOBAL MANUAL RESUSCITATORS MARKET SIZE, BY GROUP, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 20. ASEAN MANUAL RESUSCITATORS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 21. GCC MANUAL RESUSCITATORS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 22. EUROPEAN UNION MANUAL RESUSCITATORS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 23. BRICS MANUAL RESUSCITATORS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 24. G7 MANUAL RESUSCITATORS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 25. NATO MANUAL RESUSCITATORS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 26. GLOBAL MANUAL RESUSCITATORS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 27. MANUAL RESUSCITATORS MARKET SHARE, BY KEY PLAYER, 2024
  • FIGURE 28. MANUAL RESUSCITATORS MARKET, FPNV POSITIONING MATRIX, 2024

LIST OF TABLES

  • TABLE 1. MANUAL RESUSCITATORS MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2024
  • TABLE 3. GLOBAL MANUAL RESUSCITATORS MARKET SIZE, 2018-2024 (USD MILLION)
  • TABLE 4. GLOBAL MANUAL RESUSCITATORS MARKET SIZE, 2025-2032 (USD MILLION)
  • TABLE 5. GLOBAL MANUAL RESUSCITATORS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 6. GLOBAL MANUAL RESUSCITATORS MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 7. GLOBAL MANUAL RESUSCITATORS MARKET SIZE, BY AMBULATORY CENTERS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 8. GLOBAL MANUAL RESUSCITATORS MARKET SIZE, BY AMBULATORY CENTERS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 9. GLOBAL MANUAL RESUSCITATORS MARKET SIZE, BY AMBULATORY CENTERS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 10. GLOBAL MANUAL RESUSCITATORS MARKET SIZE, BY AMBULATORY CENTERS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 11. GLOBAL MANUAL RESUSCITATORS MARKET SIZE, BY AMBULATORY CENTERS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 12. GLOBAL MANUAL RESUSCITATORS MARKET SIZE, BY AMBULATORY CENTERS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 13. GLOBAL MANUAL RESUSCITATORS MARKET SIZE, BY EMERGENCY MEDICAL SERVICES, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 14. GLOBAL MANUAL RESUSCITATORS MARKET SIZE, BY EMERGENCY MEDICAL SERVICES, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 15. GLOBAL MANUAL RESUSCITATORS MARKET SIZE, BY EMERGENCY MEDICAL SERVICES, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 16. GLOBAL MANUAL RESUSCITATORS MARKET SIZE, BY EMERGENCY MEDICAL SERVICES, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 17. GLOBAL MANUAL RESUSCITATORS MARKET SIZE, BY EMERGENCY MEDICAL SERVICES, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 18. GLOBAL MANUAL RESUSCITATORS MARKET SIZE, BY EMERGENCY MEDICAL SERVICES, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 19. GLOBAL MANUAL RESUSCITATORS MARKET SIZE, BY HOME HEALTHCARE, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 20. GLOBAL MANUAL RESUSCITATORS MARKET SIZE, BY HOME HEALTHCARE, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 21. GLOBAL MANUAL RESUSCITATORS MARKET SIZE, BY HOME HEALTHCARE, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 22. GLOBAL MANUAL RESUSCITATORS MARKET SIZE, BY HOME HEALTHCARE, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 23. GLOBAL MANUAL RESUSCITATORS MARKET SIZE, BY HOME HEALTHCARE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 24. GLOBAL MANUAL RESUSCITATORS MARKET SIZE, BY HOME HEALTHCARE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 25. GLOBAL MANUAL RESUSCITATORS MARKET SIZE, BY HOSPITALS, 2018-2024 (USD MILLION)
  • TABLE 26. GLOBAL MANUAL RESUSCITATORS MARKET SIZE, BY HOSPITALS, 2025-2032 (USD MILLION)
  • TABLE 27. GLOBAL MANUAL RESUSCITATORS MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 28. GLOBAL MANUAL RESUSCITATORS MARKET SIZE, BY HOSPITALS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 29. GLOBAL MANUAL RESUSCITATORS MARKET SIZE, BY HOSPITALS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 30. GLOBAL MANUAL RESUSCITATORS MARKET SIZE, BY HOSPITALS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 31. GLOBAL MANUAL RESUSCITATORS MARKET SIZE, BY HOSPITALS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 32. GLOBAL MANUAL RESUSCITATORS MARKET SIZE, BY HOSPITALS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 33. GLOBAL MANUAL RESUSCITATORS MARKET SIZE, BY PRIVATE HOSPITALS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 34. GLOBAL MANUAL RESUSCITATORS MARKET SIZE, BY PRIVATE HOSPITALS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 35. GLOBAL MANUAL RESUSCITATORS MARKET SIZE, BY PRIVATE HOSPITALS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 36. GLOBAL MANUAL RESUSCITATORS MARKET SIZE, BY PRIVATE HOSPITALS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 37. GLOBAL MANUAL RESUSCITATORS MARKET SIZE, BY PRIVATE HOSPITALS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 38. GLOBAL MANUAL RESUSCITATORS MARKET SIZE, BY PRIVATE HOSPITALS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 39. GLOBAL MANUAL RESUSCITATORS MARKET SIZE, BY PUBLIC HOSPITALS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 40. GLOBAL MANUAL RESUSCITATORS MARKET SIZE, BY PUBLIC HOSPITALS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 41. GLOBAL MANUAL RESUSCITATORS MARKET SIZE, BY PUBLIC HOSPITALS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 42. GLOBAL MANUAL RESUSCITATORS MARKET SIZE, BY PUBLIC HOSPITALS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 43. GLOBAL MANUAL RESUSCITATORS MARKET SIZE, BY PUBLIC HOSPITALS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 44. GLOBAL MANUAL RESUSCITATORS MARKET SIZE, BY PUBLIC HOSPITALS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 45. GLOBAL MANUAL RESUSCITATORS MARKET SIZE, BY TEACHING HOSPITALS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 46. GLOBAL MANUAL RESUSCITATORS MARKET SIZE, BY TEACHING HOSPITALS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 47. GLOBAL MANUAL RESUSCITATORS MARKET SIZE, BY TEACHING HOSPITALS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 48. GLOBAL MANUAL RESUSCITATORS MARKET SIZE, BY TEACHING HOSPITALS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 49. GLOBAL MANUAL RESUSCITATORS MARKET SIZE, BY TEACHING HOSPITALS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 50. GLOBAL MANUAL RESUSCITATORS MARKET SIZE, BY TEACHING HOSPITALS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 51. GLOBAL MANUAL RESUSCITATORS MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
  • TABLE 52. GLOBAL MANUAL RESUSCITATORS MARKET SIZE, BY PRODUCT TYPE, 2025-2032 (USD MILLION)
  • TABLE 53. GLOBAL MANUAL RESUSCITATORS MARKET SIZE, BY ADULT, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 54. GLOBAL MANUAL RESUSCITATORS MARKET SIZE, BY ADULT, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 55. GLOBAL MANUAL RESUSCITATORS MARKET SIZE, BY ADULT, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 56. GLOBAL MANUAL RESUSCITATORS MARKET SIZE, BY ADULT, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 57. GLOBAL MANUAL RESUSCITATORS MARKET SIZE, BY ADULT, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 58. GLOBAL MANUAL RESUSCITATORS MARKET SIZE, BY ADULT, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 59. GLOBAL MANUAL RESUSCITATORS MARKET SIZE, BY INFANT, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 60. GLOBAL MANUAL RESUSCITATORS MARKET SIZE, BY INFANT, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 61. GLOBAL MANUAL RESUSCITATORS MARKET SIZE, BY INFANT, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 62. GLOBAL MANUAL RESUSCITATORS MARKET SIZE, BY INFANT, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 63. GLOBAL MANUAL RESUSCITATORS MARKET SIZE, BY INFANT, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 64. GLOBAL MANUAL RESUSCITATORS MARKET SIZE, BY INFANT, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 65. GLOBAL MANUAL RESUSCITATORS MARKET SIZE, BY NEONATAL, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 66. GLOBAL MANUAL RESUSCITATORS MARKET SIZE, BY NEONATAL, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 67. GLOBAL MANUAL RESUSCITATORS MARKET SIZE, BY NEONATAL, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 68. GLOBAL MANUAL RESUSCITATORS MARKET SIZE, BY NEONATAL, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 69. GLOBAL MANUAL RESUSCITATORS MARKET SIZE, BY NEONATAL, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 70. GLOBAL MANUAL RESUSCITATORS MARKET SIZE, BY NEONATAL, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 71. GLOBAL MANUAL RESUSCITATORS MARKET SIZE, BY PEDIATRIC, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 72. GLOBAL MANUAL RESUSCITATORS MARKET SIZE, BY PEDIATRIC, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 73. GLOBAL MANUAL RESUSCITATORS MARKET SIZE, BY PEDIATRIC, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 74. GLOBAL MANUAL RESUSCITATORS MARKET SIZE, BY PEDIATRIC, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 75. GLOBAL MANUAL RESUSCITATORS MARKET SIZE, BY PEDIATRIC, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 76. GLOBAL MANUAL RESUSCITATORS MARKET SIZE, BY PEDIATRIC, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 77. GLOBAL MANUAL RESUSCITATORS MARKET SIZE, BY MODE OF OPERATION, 2018-2024 (USD MILLION)
  • TABLE 78. GLOBAL MANUAL RESUSCITATORS MARKET SIZE, BY MODE OF OPERATION, 2025-2032 (USD MILLION)
  • TABLE 79. GLOBAL MANUAL RESUSCITATORS MARKET SIZE, BY REUSABLE, 2018-2024 (USD MILLION)
  • TABLE 80. GLOBAL MANUAL RESUSCITATORS MARKET SIZE, BY REUSABLE, 2025-2032 (USD MILLION)
  • TABLE 81. GLOBAL MANUAL RESUSCITATORS MARKET SIZE, BY REUSABLE, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 82. GLOBAL MANUAL RESUSCITATORS MARKET SIZE, BY REUSABLE, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 83. GLOBAL MANUAL RESUSCITATORS MARKET SIZE, BY REUSABLE, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 84. GLOBAL MANUAL RESUSCITATORS MARKET SIZE, BY REUSABLE, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 85. GLOBAL MANUAL RESUSCITATORS MARKET SIZE, BY REUSABLE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 86. GLOBAL MANUAL RESUSCITATORS MARKET SIZE, BY REUSABLE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 87. GLOBAL MANUAL RESUSCITATORS MARKET SIZE, BY AUTOCLAVABLE, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 88. GLOBAL MANUAL RESUSCITATORS MARKET SIZE, BY AUTOCLAVABLE, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 89. GLOBAL MANUAL RESUSCITATORS MARKET SIZE, BY AUTOCLAVABLE, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 90. GLOBAL MANUAL RESUSCITATORS MARKET SIZE, BY AUTOCLAVABLE, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 91. GLOBAL MANUAL RESUSCITATORS MARKET SIZE, BY AUTOCLAVABLE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 92. GLOBAL MANUAL RESUSCITATORS MARKET SIZE, BY AUTOCLAVABLE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 93. GLOBAL MANUAL RESUSCITATORS MARKET SIZE, BY NON-AUTOCLAVABLE, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 94. GLOBAL MANUAL RESUSCITATORS MARKET SIZE, BY NON-AUTOCLAVABLE, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 95. GLOBAL MANUAL RESUSCITATORS MARKET SIZE, BY NON-AUTOCLAVABLE, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 96. GLOBAL MANUAL RESUSCITATORS MARKET SIZE, BY NON-AUTOCLAVABLE, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 97. GLOBAL MANUAL RESUSCITATORS MARKET SIZE, BY NON-AUTOCLAVABLE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 98. GLOBAL MANUAL RESUSCITATORS MARKET SIZE, BY NON-AUTOCLAVABLE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 99. GLOBAL MANUAL RESUSCITATORS MARKET SIZE, BY SINGLE-USE, 2018-2024 (USD MILLION)
  • TABLE 100. GLOBAL MANUAL RESUSCITATORS MARKET SIZE, BY SINGLE-USE, 2025-2032 (USD MILLION)
  • TABLE 101. GLOBAL MANUAL RESUSCITATORS MARKET SIZE, BY SINGLE-USE, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 102. GLOBAL MANUAL RESUSCITATORS MARKET SIZE, BY SINGLE-USE, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 103. GLOBAL MANUAL RESUSCITATORS MARKET SIZE, BY SINGLE-USE, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 104. GLOBAL MANUAL RESUSCITATORS MARKET SIZE, BY SINGLE-USE, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 105. GLOBAL MANUAL RESUSCITATORS MARKET SIZE, BY SINGLE-USE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 106. GLOBAL MANUAL RESUSCITATORS MARKET SIZE, BY SINGLE-USE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 107. GLOBAL MANUAL RESUSCITATORS MARKET SIZE, BY NON-STERILE, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 108. GLOBAL MANUAL RESUSCITATORS MARKET SIZE, BY NON-STERILE, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 109. GLOBAL MANUAL RESUSCITATORS MARKET SIZE, BY NON-STERILE, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 110. GLOBAL MANUAL RESUSCITATORS MARKET SIZE, BY NON-STERILE, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 111. GLOBAL MANUAL RESUSCITATORS MARKET SIZE, BY NON-STERILE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 112. GLOBAL MANUAL RESUSCITATORS MARKET SIZE, BY NON-STERILE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 113. GLOBAL MANUAL RESUSCITATORS MARKET SIZE, BY STERILE, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 114. GLOBAL MANUAL RESUSCITATORS MARKET SIZE, BY STERILE, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 115. GLOBAL MANUAL RESUSCITATORS MARKET SIZE, BY STERILE, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 116. GLOBAL MANUAL RESUSCITATORS MARKET SIZE, BY STERILE, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 117. GLOBAL MANUAL RESUSCITATORS MARKET SIZE, BY STERILE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 118. GLOBAL MANUAL RESUSCITATORS MARKET SIZE, BY STERILE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 119. GLOBAL MANUAL RESUSCITATORS MARKET SIZE, BY SALES CHANNEL, 2018-2024 (USD MILLION)
  • TABLE 120. GLOBAL MANUAL RESUSCITATORS MARKET SIZE, BY SALES CHANNEL, 2025-2032 (USD MILLION)
  • TABLE 121. GLOBAL MANUAL RESUSCITATORS MARKET SIZE, BY DIRECT SALES, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 122. GLOBAL MANUAL RESUSCITATORS MARKET SIZE, BY DIRECT SALES, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 123. GLOBAL MANUAL RESUSCITATORS MARKET SIZE, BY DIRECT SALES, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 124. GLOBAL MANUAL RESUSCITATORS MARKET SIZE, BY DIRECT SALES, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 125. GLOBAL MANUAL RESUSCITATORS MARKET SIZE, BY DIRECT SALES, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 126. GLOBAL MANUAL RESUSCITATORS MARKET SIZE, BY DIRECT SALES, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 127. GLOBAL MANUAL RESUSCITATORS MARKET SIZE, BY HOSPITAL DISTRIBUTORS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 128. GLOBAL MANUAL RESUSCITATORS MARKET SIZE, BY HOSPITAL DISTRIBUTORS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 129. GLOBAL MANUAL RESUSCITATORS MARKET SIZE, BY HOSPITAL DISTRIBUTORS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 130. GLOBAL MANUAL RESUSCITATORS MARKET SIZE, BY HOSPITAL DISTRIBUTORS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 131. GLOBAL MANUAL RESUSCITATORS MARKET SIZE, BY HOSPITAL DISTRIBUTORS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 132. GLOBAL MANUAL RESUSCITATORS MARKET SIZE, BY HOSPITAL DISTRIBUTORS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 133. GLOBAL MANUAL RESUSCITATORS MARKET SIZE, BY ONLINE CHANNELS, 2018-2024 (USD MILLION)
  • TABLE 134. GLOBAL MANUAL RESUSCITATORS MARKET SIZE, BY ONLINE CHANNELS, 2025-2032 (USD MILLION)
  • TABLE 135. GLOBAL MANUAL RESUSCITATORS MARKET SIZE, BY ONLINE CHANNELS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 136. GLOBAL MANUAL RESUSCITATORS MARKET SIZE, BY ONLINE CHANNELS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 137. GLOBAL MANUAL RESUSCITATORS MARKET SIZE, BY ONLINE CHANNELS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 138. GLOBAL MANUAL RESUSCITATORS MARKET SIZE, BY ONLINE CHANNELS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 139. GLOBAL MANUAL RESUSCITATORS MARKET SIZE, BY ONLINE CHANNELS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 140. GLOBAL MANUAL RESUSCITATORS MARKET SIZE, BY ONLINE CHANNELS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 141. GLOBAL MANUAL RESUSCITATORS MARKET SIZE, BY COMPANY WEBSITES, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 142. GLOBAL MANUAL RESUSCITATORS MARKET SIZE, BY COMPANY WEBSITES, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 143. GLOBAL MANUAL RESUSCITATORS MARKET SIZE, BY COMPANY WEBSITES, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 144. GLOBAL MANUAL RESUSCITATORS MARKET SIZE, BY COMPANY WEBSITES, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 145. GLOBAL MANUAL RESUSCITATORS MARKET SIZE, BY COMPANY WEBSITES, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 146. GLOBAL MANUAL RESUSCITATORS MARKET SIZE, BY COMPANY WEBSITES, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 147. GLOBAL MANUAL RESUSCITATORS MARKET SIZE, BY E-COMMERCE PORTALS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 148. GLOBAL MANUAL RESUSCITATORS MARKET SIZE, BY E-COMMERCE PORTALS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 149. GLOBAL MANUAL RESUSCITATORS MARKET SIZE, BY E-COMMERCE PORTALS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 150. GLOBAL MANUAL RESUSCITATORS MARKET SIZE, BY E-COMMERCE PORTALS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 151. GLOBAL MANUAL RESUSCITATORS MARKET SIZE, BY E-COMMERCE PORTALS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 152. GLOBAL MANUAL RESUSCITATORS MARKET SIZE, BY E-COMMERCE PORTALS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 153. GLOBAL MANUAL RESUSCITATORS MARKET SIZE, BY RETAIL PHARMACIES, 2018-2024 (USD MILLION)
  • TABLE 154. GLOBAL MANUAL RESUSCITATORS MARKET SIZE, BY RETAIL PHARMACIES, 2025-2032 (USD MILLION)
  • TABLE 155. GLOBAL MANUAL RESUSCITATORS MARKET SIZE, BY RETAIL PHARMACIES, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 156. GLOBAL MANUAL RESUSCITATORS MARKET SIZE, BY RETAIL PHARMACIES, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 157. GLOBAL MANUAL RESUSCITATORS MARKET SIZE, BY RETAIL PHARMACIES, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 158. GLOBAL MANUAL RESUSCITATORS MARKET SIZE, BY RETAIL PHARMACIES, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 159. GLOBAL MANUAL RESUSCITATORS MARKET SIZE, BY RETAIL PHARMACIES, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 160. GLOBAL MANUAL RESUSCITATORS MARKET SIZE, BY RETAIL PHARMACIES, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 161. GLOBAL MANUAL RESUSCITATORS MARKET SIZE, BY CHAIN PHARMACIES, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 162. GLOBAL MANUAL RESUSCITATORS MARKET SIZE, BY CHAIN PHARMACIES, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 163. GLOBAL MANUAL RESUSCITATORS MARKET SIZE, BY CHAIN PHARMACIES, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 164. GLOBAL MANUAL RESUSCITATORS MARKET SIZE, BY CHAIN PHARMACIES, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 165. GLOBAL MANUAL RESUSCITATORS MARKET SIZE, BY CHAIN PHARMACIES, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 166. GLOBAL MANUAL RESUSCITATORS MARKET SIZE, BY CHAIN PHARMACIES, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 167. GLOBAL MANUAL RESUSCITATORS MARKET SIZE, BY INDEPENDENT PHARMACIES, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 168. GLOBAL MANUAL RESUSCITATORS MARKET SIZE, BY INDEPENDENT PHARMACIES, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 169. GLOBAL MANUAL RESUSCITATORS MARKET SIZE, BY INDEPENDENT PHARMACIES, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 170. GLOBAL MANUAL RESUSCITATORS MARKET SIZE, BY INDEPENDENT PHARMACIES, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 171. GLOBAL MANUAL RESUSCITATORS MARKET SIZE, BY INDEPENDENT PHARMACIES, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 172. GLOBAL MANUAL RESUSCITATORS MARKET SIZE, BY INDEPENDENT PHARMACIES, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 173. GLOBAL MANUAL RESUSCITATORS MARKET SIZE, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 174. GLOBAL MANUAL RESUSCITATORS MARKET SIZE, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 175. AMERICAS MANUAL RESUSCITATORS MARKET SIZE, BY SUBREGION, 2018-2024 (USD MILLION)
  • TABLE 176. AMERICAS MANUAL RESUSCITATORS MARKET SIZE, BY SUBREGION, 2025-2032 (USD MILLION)
  • TABLE 177. AMERICAS MANUAL RESUSCITATORS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 178. AMERICAS MANUAL RESUSCITATORS MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 179. AMERICAS MANUAL RESUSCITATORS MARKET SIZE, BY HOSPITALS, 2018-2024 (USD MILLION)
  • TABLE 180. AMERICAS MANUAL RESUSCITATORS MARKET SIZE, BY HOSPITALS, 2025-2032 (USD MILLION)
  • TABLE 181. AMERICAS MANUAL RESUSCITATORS MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
  • TABLE 182. AMERICAS MANUAL RESUSCITATORS MARKET SIZE, BY PRODUCT TYPE, 2025-2032 (USD MILLION)
  • TABLE 183. AMERICAS MANUAL RESUSCITATORS MARKET SIZE, BY MODE OF OPERATION, 2018-2024 (USD MILLION)
  • TABLE 184. AMERICAS MANUAL RESUSCITATORS MARKET SIZE, BY MODE OF OPERATION, 2025-2032 (USD MILLION)
  • TABLE 185. AMERICAS MANUAL RESUSCITATORS MARKET SIZE, BY REUSABLE, 2018-2024 (USD MILLION)
  • TABLE 186. AMERICAS MANUAL RESUSCITATORS MARKET SIZE, BY REUSABLE, 2025-2032 (USD MILLION)
  • TABLE 187. AMERICAS MANUAL RESUSCITATORS MARKET SIZE, BY SINGLE-USE, 2018-2024 (USD MILLION)
  • TABLE 188. AMERICAS MANUAL RESUSCITATORS MARKET SIZE, BY SINGLE-USE, 2025-2032 (USD MILLION)
  • TABLE 189. AMERICAS MANUAL RESUSCITATORS MARKET SIZE, BY SALES CHANNEL, 2018-2024 (USD MILLION)
  • TABLE 190. AMERICAS MANUAL RESUSCITATORS MARKET SIZE, BY SALES CHANNEL, 2025-2032 (USD MILLION)
  • TABLE 191. AMERICAS MANUAL RESUSCITATORS MARKET SIZE, BY ONLINE CHANNELS, 2018-2024 (USD MILLION)
  • TABLE 192. AMERICAS MANUAL RESUSCITATORS MARKET SIZE, BY ONLINE CHANNELS, 2025-2032 (USD MILLION)
  • TABLE 193. AMERICAS MANUAL RESUSCITATORS MARKET SIZE, BY RETAIL PHARMACIES, 2018-2024 (USD MILLION)
  • TABLE 194. AMERICAS MANUAL RESUSCITATORS MARKET SIZE, BY RETAIL PHARMACIES, 2025-2032 (USD MILLION)
  • TABLE 195. NORTH AMERICA MANUAL RESUSCITATORS MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 196. NORTH AMERICA MANUAL RESUSCITATORS MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 197. NORTH AMERICA MANUAL RESUSCITATORS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 198. NORTH AMERICA MANUAL RESUSCITATORS MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 199. NORTH AMERICA MANUAL RESUSCITATORS MARKET SIZE, BY HOSPITALS, 2018-2024 (USD MILLION)
  • TABLE 200. NORTH AMERICA MANUAL RESUSCITATORS MARKET SIZE, BY HOSPITALS, 2025-2032 (USD MILLION)
  • TABLE 201. NORTH AMERICA MANUAL RESUSCITATORS MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
  • TABLE 202. NORTH AMERICA MANUAL RESUSCITATORS MARKET SIZE, BY PRODUCT TYPE, 2025-2032 (USD MILLION)
  • TABLE 203. NORTH AMERICA MANUAL RESUSCITATORS MARKET SIZE, BY MODE OF OPERATION, 2018-2024 (USD MILLION)
  • TABLE 204. NORTH AMERICA MANUAL RESUSCITATORS MARKET SIZE, BY MODE OF OPERATION, 2025-2032 (USD MILLION)
  • TABLE 205. NORTH AMERICA MANUAL RESUSCITATORS MARKET SIZE, BY REUSABLE, 2018-2024 (USD MILLION)
  • TABLE 206. NORTH AMERICA MANUAL RESUSCITATORS MARKET SIZE, BY REUSABLE, 2025-2032 (USD MILLION)
  • TABLE 207. NORTH AMERICA MANUAL RESUSCITATORS MARKET SIZE, BY SINGLE-USE, 2018-2024 (USD MILLION)
  • TABLE 208. NORTH AMERICA MANUAL RESUSCITATORS MARKET SIZE, BY SINGLE-USE, 2025-2032 (USD MILLION)
  • TABLE 209. NORTH AMERICA MANUAL RESUSCITATORS MARKET SIZE, BY SALES CHANNEL, 2018-2024 (USD MILLION)
  • TABLE 210. NORTH AMERICA MANUAL RESUSCITATORS MARKET SIZE, BY SALES CHANNEL, 2025-2032 (USD MILLION)
  • TABLE 211. NORTH AMERICA MANUAL RESUSCITATORS MARKET SIZE, BY ONLINE CHANNELS, 2018-2024 (USD MILLION)
  • TABLE 212. NORTH AMERICA MANUAL RESUSCITATORS MARKET SIZE, BY ONLINE CHANNELS, 2025-2032 (USD MILLION)
  • TABLE 213. NORTH AMERICA MANUAL RESUSCITATORS MARKET SIZE, BY RETAIL PHARMACIES, 2018-2024 (USD MILLION)
  • TABLE 214. NORTH AMERICA MANUAL RESUSCITATORS MARKET SIZE, BY RETAIL PHARMACIES, 2025-2032 (USD MILLION)
  • TABLE 215. LATIN AMERICA MANUAL RESUSCITATORS MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 216. LATIN AMERICA MANUAL RESUSCITATORS MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 217. LATIN AMERICA MANUAL RESUSCITATORS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 218. LATIN AMERICA MANUAL RESUSCITATORS MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 219. LATIN AMERICA MANUAL RESUSCITATORS MARKET SIZE, BY HOSPITALS, 2018-2024 (USD MILLION)
  • TABLE 220. LATIN AMERICA MANUAL RESUSCITATORS MARKET SIZE, BY HOSPITALS, 2025-2032 (USD MILLION)
  • TABLE 221. LATIN AMERICA MANUAL RESUSCITATORS MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
  • TABLE 222. LATIN AMERICA MANUAL RESUSCITATORS MARKET SIZE, BY PRODUCT TYPE, 2025-2032 (USD MILLION)
  • TABLE 223. LATIN AMERICA MANUAL RESUSCITATORS MARKET SIZE, BY MODE OF OPERATION, 2018-2024 (USD MILLION)
  • TABLE 224. LATIN AMERICA MANUAL RESUSCITATORS MARKET SIZE, BY MODE OF OPERATION, 2025-2032 (USD MILLION)
  • TABLE 225. LATIN AMERICA MANUAL RESUSCITATORS MARKET SIZE, BY REUSABLE, 2018-2024 (USD MILLION)
  • TABLE 226. LATIN AMERICA MANUAL RESUSCITATORS MARKET SIZE, BY REUSABLE, 2025-2032 (USD MILLION)
  • TABLE 227. LATIN AMERICA MANUAL RESUSCITATORS MARKET SIZE, BY SINGLE-USE, 2018-2024 (USD MILLION)
  • TABLE 228. LATIN AMERICA MANUAL RESUSCITATORS MARKET SIZE, BY SINGLE-USE, 2025-2032 (USD MILLION)
  • TABLE 229. LATIN AMERICA MANUAL RESUSCITATORS MARKET SIZE, BY SALES CHANNEL, 2018-2024 (USD MILLION)
  • TABLE 230. LATIN AMERICA MANUAL RESUSCITATORS MARKET SIZE, BY SALES CHANNEL, 2025-2032 (USD MILLION)
  • TABLE 231. LATIN AMERICA MANUAL RESUSCITATORS MARKET SIZE, BY ONLINE CHANNELS, 2018-2024 (USD MILLION)
  • TABLE 232. LATIN AMERICA MANUAL RESUSCITATORS MARKET SIZE, BY ONLINE CHANNELS, 2025-2032 (USD MILLION)
  • TABLE 233. LATIN AMERICA MANUAL RESUSCITATORS MARKET SIZE, BY RETAIL PHARMACIES, 2018-2024 (USD MILLION)
  • TABLE 234. LATIN AMERICA MANUAL RESUSCITATORS MARKET SIZE, BY RETAIL PHARMACIES, 2025-2032 (USD MILLION)
  • TABLE 235. EUROPE, MIDDLE EAST & AFRICA MANUAL RESUSCITATORS MARKET SIZE, BY SUBREGION, 2018-2024 (USD MILLION)
  • TABLE 236. EUROPE, MIDDLE EAST & AFRICA MANUAL RESUSCITATORS MARKET SIZE, BY SUBREGION, 2025-2032 (USD MILLION)
  • TABLE 237. EUROPE, MIDDLE EAST & AFRICA MANUAL RESUSCITATORS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 238. EUROPE, MIDDLE EAST & AFRICA MANUAL RESUSCITATORS MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 239. EUROPE, MIDDLE EAST & AFRICA MANUAL RESUSCITATORS MARKET SIZE, BY HOSPITALS, 2018-2024 (USD MILLION)
  • TABLE 240. EUROPE, MIDDLE EAST & AFRICA MANUAL RESUSCITATORS MARKET SIZE, BY HOSPITALS, 2025-2032 (USD MILLION)
  • TABLE 241. EUROPE, MIDDLE EAST & AFRICA MANUAL RESUSCITATORS MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
  • TABLE 242. EUROPE, MIDDLE EAST & AFRICA MANUAL RESUSCITATORS MARKET SIZE, BY PRODUCT TYPE, 2025-2032 (USD MILLION)
  • TABLE 243. EUROPE, MIDDLE EAST & AFRICA MANUAL RESUSCITATORS MARKET SIZE, BY MODE OF OPERATION, 2018-2024 (USD MILLION)
  • TABLE 244. EUROPE, MIDDLE EAST & AFRICA MANUAL RESUSCITATORS MARKET SIZE, BY MODE OF OPERATION, 2025-2032 (USD MILLION)
  • TABLE 245. EUROPE, MIDDLE EAST & AFRICA MANUAL RESUSCITATORS MARKET SIZE, BY REUSABLE, 2018-2024 (USD MILLION)
  • TABLE 246. EUROPE, MIDDLE EAST & AFRICA MANUAL RESUSCITATORS MARKET SIZE, BY REUSABLE, 2025-2032 (USD MILLION)
  • TABLE 247. EUROPE, MIDDLE EAST & AFRICA MANUAL RESUSCITATORS MARKET SIZE, BY SINGLE-USE, 2018-2024 (USD MILLION)
  • TABLE 248. EUROPE, MIDDLE EAST & AFRICA MANUAL RESUSCITATORS MARKET SIZE, BY SINGLE-USE, 2025-2032 (USD MILLION)
  • TABLE 249. EUROPE, MIDDLE EAST & AFRICA MANUAL RESUSCITATORS MARKET SIZE, BY SALES CHANNEL, 2018-2024 (USD MILLION)
  • TABLE 250. EUROPE, MIDDLE EAST & AFRICA MANUAL RESUSCITATORS MARKET SIZE, BY SALES CHANNEL, 2025-2032 (USD MILLION)
  • TABLE 251. EUROPE, MIDDLE EAST & AFRICA MANUAL RESUSCITATORS MARKET SIZE, BY ONLINE CHANNELS, 2018-2024 (USD MILLION)
  • TABLE 252. EUROPE, MIDDLE EAST & AFRICA MANUAL RESUSCITATORS MARKET SIZE, BY ONLINE CHANNELS, 2025-2032 (USD MILLION)
  • TABLE 253. EUROPE, MIDDLE EAST & AFRICA MANUAL RESUSCITATORS MARKET SIZE, BY RETAIL PHARMACIES, 2018-2024 (USD MILLION)
  • TABLE 254. EUROPE, MIDDLE EAST & AFRICA MANUAL RESUSCITATORS MARKET SIZE, BY RETAIL PHARMACIES, 2025-2032 (USD MILLION)
  • TABLE 255. EUROPE MANUAL RESUSCITATORS MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 256. EUROPE MANUAL RESUSCITATORS MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 257. EUROPE MANUAL RESUSCITATORS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 258. EUROPE MANUAL RESUSCITATORS MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 259. EUROPE MANUAL RESUSCITATORS MARKET SIZE, BY HOSPITALS, 2018-2024 (USD MILLION)
  • TABLE 260. EUROPE MANUAL RESUSCITATORS MARKET SIZE, BY HOSPITALS, 2025-2032 (USD MILLION)
  • TABLE 261. EUROPE MANUAL RESUSCITATORS MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
  • TABLE 262. EUROPE MANUAL RESUSCITATORS MARKET SIZE, BY PRODUCT TYPE, 2025-2032 (USD MILLION)
  • TABLE 263. EUROPE MANUAL RESUSCITATORS MARKET SIZE, BY MODE OF OPERATION, 2018-2024 (USD MILLION)
  • TABLE 264. EUROPE MANUAL RESUSCITATORS MARKET SIZE, BY MODE OF OPERATION, 2025-2032 (USD MILLION)
  • TABLE 265. EUROPE MANUAL RESUSCITATORS MARKET SIZE, BY REUSABLE, 2018-2024 (USD MILLION)
  • TABLE 266. EUROPE MANUAL RESUSCITATORS MARKET SIZE, BY REUSABLE, 2025-2032 (USD MILLION)
  • TABLE 267. EUROPE MANUAL RESUSCITATORS MARKET SIZE, BY SINGLE-USE, 2018-2024 (USD MILLION)
  • TABLE 268. EUROPE MANUAL RESUSCITATORS MARKET SIZE, BY SINGLE-USE, 2025-2032 (USD MILLION)
  • TABLE 269. EUROPE MANUAL RESUSCITATORS MARKET SIZE, BY SALES CHANNEL, 2018-2024 (USD MILLION)
  • TABLE 270. EUROPE MANUAL RESUSCITATORS MARKET SIZE, BY SALES CHANNEL, 2025-2032 (USD MILLION)
  • TABLE 271. EUROPE MANUAL RESUSCITATORS MARKET SIZE, BY ONLINE CHANNELS, 2018-2024 (USD MILLION)
  • TABLE 272. EUROPE MANUAL RESUSCITATORS MARKET SIZE, BY ONLINE CHANNELS, 2025-2032 (USD MILLION)
  • TABLE 273. EUROPE MANUAL RESUSCITATORS MARKET SIZE, BY RETAIL PHARMACIES, 2018-2024 (USD MILLION)
  • TABLE 274. EUROPE MANUAL RESUSCITATORS MARKET SIZE, BY RETAIL PHARMACIES, 2025-2032 (USD MILLION)
  • TABLE 275. MIDDLE EAST MANUAL RESUSCITATORS MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 276. MIDDLE EAST MANUAL RESUSCITATORS MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 277. MIDDLE EAST MANUAL RESUSCITATORS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 278. MIDDLE EAST MANUAL RESUSCITATORS MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 279. MIDDLE EAST MANUAL RESUSCITATORS MARKET SIZE, BY HOSPITALS, 2018-2024 (USD MILLION)
  • TABLE 280. MIDDLE EAST MANUAL RESUSCITATORS MARKET SIZE, BY HOSPITALS, 2025-2032 (USD MILLION)
  • TABLE 281. MIDDLE EAST MANUAL RESUSCITATORS MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
  • TABLE 282. MIDDLE EAST MANUAL RESUSCITATORS MARKET SIZE, BY PRODUCT TYPE, 2025-2032 (USD MILLION)
  • TABLE 283. MIDDLE EAST MANUAL RESUSCITATORS MARKET SIZE, BY MODE OF OPERATION, 2018-2024 (USD MILLION)
  • TABLE 284. MIDDLE EAST MANUAL RESUSCITATORS MARKET SIZE, BY MODE OF OPERATION, 2025-2032 (USD MILLION)
  • TABLE 285. MIDDLE EAST MANUAL RESUSCITATORS MARKET SIZE, BY REUSABLE, 2018-2024 (USD MILLION)
  • TABLE 286. MIDDLE EAST MANUAL RESUSCITATORS MARKET SIZE, BY REUSABLE, 2025-2032 (USD MILLION)
  • TABLE 287. MIDDLE EAST MANUAL RESUSCITATORS MARKET SIZE, BY SINGLE-USE, 2018-2024 (USD MILLION)
  • TABLE 288. MIDDLE EAST MANUAL RESUSCITATORS MARKET SIZE, BY SINGLE-USE, 2025-2032 (USD MILLION)
  • TABLE 289. MIDDLE EAST MANUAL RESUSCITATORS MARKET SIZE, BY SALES CHANNEL, 2018-2024 (USD MILLION)
  • TABLE 290. MIDDLE EAST MANUAL RESUSCITATORS MARKET SIZE, BY SALES CHANNEL, 2025-2032 (USD MILLION)
  • TABLE 291. MIDDLE EAST MANUAL RESUSCITATORS MARKET SIZE, BY ONLINE CHANNELS, 2018-2024 (USD MILLION)
  • TABLE 292. MIDDLE EAST MANUAL RESUSCITATORS MARKET SIZE, BY ONLINE CHANNELS, 2025-2032 (USD MILLION)
  • TABLE 293. MIDDLE EAST MANUAL RESUSCITATORS MARKET SIZE, BY RETAIL PHARMACIES, 2018-2024 (USD MILLION)
  • TABLE 294. MIDDLE EAST MANUAL RESUSCITATORS MARKET SIZE, BY RETAIL PHARMACIES, 2025-2032 (USD MILLION)
  • TABLE 295. AFRICA MANUAL RESUSCITATORS MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 296. AFRICA MANUAL RESUSCITATORS MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 297. AFRICA MANUAL RESUSCITATORS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 298. AFRICA MANUAL RESUSCITATORS MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 299. AFRICA MANUAL RESUSCITATORS MARKET SIZE, BY HOSPITALS, 2018-2024 (USD MILLION)
  • TABLE 300. AFRICA MANUAL RESUSCITATORS MARKET SIZE, BY HOSPITALS, 2025-2032 (USD MILLION)
  • TABLE 301. AFRICA MANUAL RESUSCITATORS MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
  • TABLE 302. AFRICA MANUAL RESUSCITATORS MARKET SIZE, BY PRODUCT TYPE, 2025-2032 (USD MILLION)
  • TABLE 303. AFRICA MANUAL RESUSCITATORS MARKET SIZE, BY MODE OF OPERATION, 2018-2024 (USD MILLION)
  • TABLE 304. AFRICA MANUAL RESUSCITATORS MARKET SIZE, BY MODE OF OPERATION, 2025-2032 (USD MILLION)
  • TABLE 305. AFRICA MANUAL RESUSCITATORS MARKET SIZE, BY REUSABLE, 2018-2024 (USD MILLION)
  • TABLE 306. AFRICA MANUAL RESUSCITATORS MARKET SIZE, BY REUSABLE, 2025-2032 (USD MILLION)
  • TABLE 307. AFRICA MANUAL RESUSCITATORS MARKET SIZE, BY SINGLE-USE, 2018-2024 (USD MILLION)
  • TABLE 308. AFRICA MANUAL RESUSCITATORS MARKET SIZE, BY SINGLE-USE, 2025-2032 (USD MILLION)
  • TABLE 309. AFRICA MANUAL RESUSCITATORS MARKET SIZE, BY SALES CHANNEL, 2018-2024 (USD MILLION)
  • TABLE 310. AFRICA MANUAL RESUSCITATORS MARKET SIZE, BY SALES CHANNEL, 2025-2032 (USD MILLION)
  • TABLE 311. AFRICA MANUAL RESUSCITATORS MARKET SIZE, BY ONLINE CHANNELS, 2018-2024 (USD MILLION)
  • TABLE 312. AFRICA MANUAL RESUSCITATORS MARKET SIZE, BY ONLINE CHANNELS, 2025-2032 (USD MILLION)
  • TABLE 313. AFRICA MANUAL RESUSCITATORS MARKET SIZE, BY RETAIL PHARMACIES, 2018-2024 (USD MILLION)
  • TABLE 314. AFRICA MANUAL RESUSCITATORS MARKET SIZE, BY RETAIL PHARMACIES, 2025-2032 (USD MILLION)
  • TABLE 315. ASIA-PACIFIC MANUAL RESUSCITATORS MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 316. ASIA-PACIFIC MANUAL RESUSCITATORS MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 317. ASIA-PACIFIC MANUAL RESUSCITATORS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 318. ASIA-PACIFIC MANUAL RESUSCITATORS MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 319. ASIA-PACIFIC MANUAL RESUSCITATORS MARKET SIZE, BY HOSPITALS, 2018-2024 (USD MILLION)
  • TABLE 320. ASIA-PACIFIC MANUAL RESUSCITATORS MARKET SIZE, BY HOSPITALS, 2025-2032 (USD MILLION)
  • TABLE 321. ASIA-PACIFIC MANUAL RESUSCITATORS MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
  • TABLE 322. ASIA-PACIFIC MANUAL RESUSCITATORS MARKET SIZE, BY PRODUCT TYPE, 2025-2032 (USD MILLION)
  • TABLE 323. ASIA-PACIFIC MANUAL RESUSCITATORS MARKET SIZE, BY MODE OF OPERATION, 2018-2024 (USD MILLION)
  • TABLE 324. ASIA-PACIFIC MANUAL RESUSCITATORS MARKET SIZE, BY MODE OF OPERATION, 2025-2032 (USD MILLION)
  • TABLE 325. ASIA-PACIFIC MANUAL RESUSCITATORS MARKET SIZ